Sutykine - Sunitinib 50mg 70 Capsules (Sutent) - Anticancer Medication

SUNITINIB 50 mg (Sutykine) x 70 Capsules

$300.00 $150.00
image Prescription Required

Sutykine is an oral targeted therapy that contains Sunitinib 50 mg Malate, used in the treatment of advanced cancers such as renal cell carcinoma (kidney cancer), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors.

Generic Name Sunitinib
Manufacturer Intas Pharmaceuticals Ltd
Packing 70 Capsules
Prescribed For Anticancer
Availability In Stock
Shipping to USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries.

Contact us on WhatsApp

Genuine Medicines

Quick Air Delivery

Secure Payment

24/7 Support

Benefits of SUNITINIB 50 mg

  • Helps manage tumor-related complications
  • Supports advanced oncology care
  • Used in modern cancer treatment
  • Helps slow abnormal cancer growth
  • May improve long-term wellness
  • Supports comprehensive cancer management

Side Effects

  • Fatigue and weakness
  • High blood pressure
  • Nausea, vomiting, and diarrhea
  • Mouth sores
  • Loss of appetite
  • Hair and skin color changes
  • Hand-foot syndrome (redness, pain, peeling)
  • Low blood counts (anemia, neutropenia)
  • Underactive thyroid (hypothyroidism)

Caution

  • Take exactly as prescribed.
  • Do not skip or stop doses.
  • Inform your doctor of heart, liver, or kidney problems.
  • Monitor blood pressure and liver function regularly.
  • Avoid grapefruit or grapefruit juice.
  • Store in a cool, dry place away from children.
  • Do not share medication.

Disclaimer

This website operates in compliance with applicable pharmaceutical laws. All content and data available on this website are intended solely for informational purposes. The information provided is not a substitute for professional medical advice, diagnosis, or treatment. Information provided here is for general awareness and does not replace medical advice. We strongly encourage you to consult a qualified healthcare professional for guidance.

Author

Reviewed By

Dr. Abhinav Narang

Doctor of Medicine (MD) | Professional Interest in Oncology

Dr. Abhinav Narang holds a Doctor of Medicine (MD) degree and has a professional interest in oncology and cancer care. His interests include anticancer therapies, monitoring treatment response, managing treatment-related side effects and providing supportive care throughout the patient’s treatment journey.

Need assistance? Chat with us